Drug agency Pfizer Ltd. on Saturday reported 52.11% decline in web profit to ₹148.96 crore for the second quarter ended September.
The firm had logged a web profit of ₹311.07 crore in July-September interval a yr earlier, in accordance to a regulatory submitting by Pfizer.
Revenue from operations declined 9.76% to ₹575.21 crore within the quarter as in opposition to ₹637.47 crore within the year-earlier interval.
Total expense was at ₹410.76 crore, down 5.66%.
Total earnings was at ₹611.28 crore in September quarter 2023-24, down 7.62%.
